Phase 2 Study Of Pevonedistat Plus Azacitidine Vs Azacitidine In Patients With High-Risk Myelodisplasic Syndrome (Mds), Chronic Myelomonocytic Leukemia (Cmml) Or Acute Myeloid Leukemia (Aml) <30% Blast (Nct02610777)
HAEMATOLOGICA（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要